CMA Clinical Spotlight: Becker Muscular Dystrophy by Dr Amrita Singh. This article is valued at one hour of CMA CPD.
Becker muscular dystrophy (BMD) is a rare inherited muscle-wasting condition that causes progressive weakness of the skeletal muscles, particularly those around the hips, thighs, pelvis, and shoulders. It belongs to the group of conditions known as muscular dystrophies, which affect muscle structure and function over time (Muscular Dystrophy Association, 2018).
Becker muscular dystrophy is caused by changes in the DMD gene, which provides instructions for making dystrophin, a protein needed to help protect and stabilise muscle fibres. In BMD, the body produces some dystrophin, but it is either reduced in amount or does not work properly. This makes the condition generally less severe and slower progressing than Duchenne muscular dystrophy, where dystrophin is usually absent or nearly absent (Hopkins medicine, n.d.; Thada et. al., 2020).
Symptoms often begin in childhood, adolescence, or early adulthood, although the age of onset and severity can vary widely. Individuals may experience difficulty running, climbing stairs, rising from the floor, frequent falls, muscle cramps, or enlargement of the calf muscles (Cleveland Clinic, 2022).
Although Becker muscular dystrophy primarily affects skeletal muscles, it can also involve the heart muscle, leading to cardiomyopathy in some individuals. For this reason, regular medical monitoring is important, even when muscle symptoms appear mild (Thada et. al., 2020; Muscular Dystrophy Association, 2018).
Becker muscular dystrophy is usually inherited in an X-linked recessive pattern, meaning it mostly affects males, while females may be carriers and can sometimes develop milder symptoms. Management focuses on maintaining mobility, monitoring heart and respiratory health, supporting independence, and improving quality of life (Hopkins medicine, n.d.; Cleveland Clinic, 2026).
Beckham Muscular Dystrophy – Causes
Becker muscular dystrophy is caused by genetic changes in the DMD gene, which is responsible for producing dystrophin, a protein that helps protect and stabilise muscle fibres during movement. When dystrophin is reduced or abnormal, muscle cells become more vulnerable to damage and gradually weaken over time (Cleveland Clinic, 2022; Hopkins medicine, n.d.).
The DMD gene is located on the X chromosome, which is why Becker muscular dystrophy usually follows an X-linked recessive inheritance pattern. Males are more commonly affected because they typically have one X chromosome; if that X chromosome carries the altered DMD gene, they are more likely to develop symptoms (Hopkins medicine, n.d.; Cleveland Clinic, 2022).
In Becker muscular dystrophy, the genetic change usually allows the body to produce some partially functional dystrophin. This is why BMD is generally milder and progresses more slowly than Duchenne muscular dystrophy, where dystrophin is usually absent or nearly absent (Hopkins medicine, n.d.; Cleveland Clinic, 2022).
Females may be carriers of the altered DMD gene. Many carriers have no symptoms, but some may develop mild muscle weakness, raised creatine kinase levels, or heart-related involvement, so genetic counselling and medical monitoring may be relevant in affected families (Cleveland Clinic, 2022; Hopkins medicine, n.d.).
In some individuals, Becker muscular dystrophy occurs due to a new genetic variant, meaning there may be no known family history. Overall, the condition is caused by changes affecting dystrophin production, leading to progressive muscle fibre damage, weakness, and, in some cases, cardiac involvement (Thada et. al., 2020).
Becker Muscular Dystrophy – Signs and symptoms
The signs and symptoms of Becker muscular dystrophy (BMD) usually develop gradually and vary widely between individuals. Symptoms often begin in childhood, adolescence, or early adulthood, and progression is generally slower than in Duchenne muscular dystrophy (Cleveland Clinic, 2022; Hopkins medicine, n.d.).
One of the earliest symptoms is progressive muscle weakness, especially affecting the muscles of the hips, pelvis, thighs, and shoulders. This may lead to difficulty running, climbing stairs, jumping, rising from the floor, or getting up from a seated position (Thada et. al., 2020; Muscular Dystrophy Association, 2018).
Individuals may also experience frequent falls, muscle cramps, fatigue, and reduced exercise tolerance. Some may develop a waddling gait or walk on their toes due to muscle weakness and changes in posture or balance (Cleveland Clinic, 2022).
A common physical sign is calf muscle enlargement, also known as pseudohypertrophy. Although the calves may appear larger, this is due to replacement of muscle tissue with fat and connective tissue rather than increased muscle strength (Hopkins medicine, n.d.; Cleveland Clinic, 2022).
As the condition progresses, weakness may affect mobility and daily activities. Some individuals may eventually require mobility aids, although many people with Becker muscular dystrophy remain walking for longer compared with Duchenne muscular dystrophy (Muscular Dystrophy Association, 2018; Thada et. al., 2020).
Becker muscular dystrophy can also affect the heart muscle, leading to cardiomyopathy or irregular heart rhythms in some individuals. In some cases, heart involvement may occur even when skeletal muscle symptoms are mild, making regular cardiac monitoring important (Cleveland Clinic, 2022; Hopkins medicine, n.d.).
Becker Muscular Dystrophy – Risk factors
The main risk factor for Becker muscular dystrophy (BMD) is having a genetic change in the DMD gene, which affects the production or function of dystrophin, a protein needed for healthy muscle fibres (Cleveland Clinic, 2022; Hopkins medicine, n.d.).
Because BMD is usually inherited in an X-linked recessive pattern, being male is a significant risk factor. Males are more commonly affected because they typically have one X chromosome; if that chromosome carries the altered DMD gene, symptoms are more likely to develop (Hopkins medicine, n.d.).
A family history of Becker muscular dystrophy or Duchenne muscular dystrophy increases risk, particularly when there are affected male relatives or known female carriers in the family. Genetic counselling may be helpful for families with a history of DMD gene-related conditions (Cleveland Clinic, 2022; Thada et. al., 2020).
Having a carrier mother is another important risk factor. Female carriers may pass the altered DMD gene to their children. Sons who inherit the altered gene may develop Becker muscular dystrophy, while daughters may become carriers and, in some cases, may develop milder symptoms or heart involvement (Hopkins medicine, n.d.; Cleveland Clinic, 2022).
In some cases, Becker muscular dystrophy may occur due to a new genetic variant, meaning there may be no known family history. Therefore, absence of family history does not completely exclude the condition (Muscular Dystrophy Association, 2018).
Becker Muscular Dystrophy – Complications
Becker muscular dystrophy can lead to several complications as muscle weakness progresses over time. The severity and timing of complications vary widely between individuals, and some people may remain mobile for many years, while others may develop increasing functional limitations (Cleveland Clinic, 2022; Muscular Dystrophy Association, 2018).
One of the most important complications is cardiomyopathy, where the heart muscle becomes weakened or enlarged. This can affect the heart’s ability to pump blood effectively and may lead to symptoms such as breathlessness, fatigue, palpitations, or reduced exercise tolerance. In some individuals, heart involvement may occur even when skeletal muscle weakness is relatively mild, making regular cardiac monitoring essential (Hopkins medicine, n.d.; Thada et. al., 2020).
Progressive weakness of the hips, thighs, pelvis, shoulders, and trunk muscles may lead to difficulty walking, climbing stairs, rising from the floor, maintaining posture, or carrying out daily activities. Some individuals may eventually require mobility aids or wheelchair support, depending on disease progression (Cleveland Clinic, 2022; Muscular Dystrophy Association, 2018).
Muscle weakness and reduced mobility may also contribute to joint stiffness, contractures, falls, pain, and reduced independence. Contractures occur when muscles or tendons become shortened, limiting joint movement and affecting posture or mobility (Thada et. al., 2020).
Respiratory complications may occur in more advanced disease if breathing muscles become affected. This can reduce breathing efficiency, increase fatigue, and raise the risk of respiratory infections or sleep-related breathing difficulties (Muscular Dystrophy Association, 2018).
Becker muscular dystrophy – Types / stages
Becker muscular dystrophy is itself a type of muscular dystrophy, specifically a dystrophin-related muscular dystrophy caused by changes in the DMD gene. It is closely related to Duchenne muscular dystrophy, but Becker muscular dystrophy is usually milder, later in onset, and slower in progression because some partially functional dystrophin is still produced (Cleveland Clinic, 2022; Hopkins medicine, n.d.; Thada et. al., 2020).
Becker muscular dystrophy is not usually divided into formal “grades” in the same way as some injuries or cancers. Instead, it is commonly described according to stage of progression, mobility, muscle involvement, and cardiac or respiratory complications (Cleveland Clinic, 2022; Muscular Dystrophy Association, 2018).
1. Early stage
In the early stage, symptoms may be mild and gradually developing. Individuals may experience difficulty running, climbing stairs, jumping, rising from the floor, muscle cramps, fatigue, frequent falls, or calf muscle enlargement. Some people may remain active for many years during this stage (Cleveland Clinic, 2022; Hopkins medicine, n.d.).
2. Ambulatory stage
During the ambulatory stage, the individual is still able to walk, although muscle weakness may become more noticeable. There may be increasing difficulty with stairs, long distances, sports, standing from a seated position, or maintaining balance. Physiotherapy, stretching, and monitoring can help preserve mobility and reduce complications (Thada et. al., 2020; Muscular Dystrophy Association, 2018).
3. Progressive mobility-limitation stage
As the condition progresses, weakness of the hips, thighs, pelvis, shoulders, and trunk may lead to greater difficulty with walking and daily activities. Some individuals may need braces, walking aids, or other mobility support. Contractures, pain, fatigue, and reduced independence may become more relevant at this stage (Cleveland Clinic, 2022; Muscular Dystrophy Association, 2018).
4. Non-ambulatory or advanced stage
Some individuals may eventually lose the ability to walk independently and require wheelchair support. Not everyone with Becker muscular dystrophy reaches this stage early, and progression varies widely between individuals (Cleveland Clinic, 2022; Thada et. al., 2020).
5. Cardiac involvement stage
Becker muscular dystrophy may affect the heart muscle at any stage, sometimes even when skeletal muscle symptoms are mild. Cardiac complications may include cardiomyopathy or irregular heart rhythms, so regular cardiac monitoring is important throughout life (Hopkins medicine, n.d.; Cleveland Clinic, 2022).
6. Respiratory involvement stage
In more advanced disease, weakness may affect breathing muscles, increasing the risk of reduced breathing efficiency, sleep-related breathing problems, or respiratory infections. Respiratory assessment may be needed if symptoms suggest breathing involvement (Muscular Dystrophy Association, 2018; Thada et. al., 2020).
Becker Muscular Dystrophy – Prognosis
The prognosis of Becker muscular dystrophy (BMD) varies widely between individuals, depending on the specific DMD gene change, age of symptom onset, degree of muscle weakness, cardiac involvement, respiratory function, and access to ongoing monitoring and supportive care (Cleveland Clinic, 2022; Hopkins medicine, n.d.).
Compared with Duchenne muscular dystrophy, Becker muscular dystrophy is usually slower progressing and less severe, because the body produces some dystrophin, although it may be reduced or not fully functional. Many individuals remain able to walk into adulthood, although mobility may gradually decline over time (Cleveland Clinic, 2022; Muscular Dystrophy Association, 2018).
The long-term outlook is strongly influenced by heart involvement, particularly cardiomyopathy, which can occur even when skeletal muscle weakness is mild. Regular cardiac monitoring and early management of heart complications are therefore important for improving long-term outcomes (Hopkins medicine, n.d.; Thada et. al., 2020).
Respiratory involvement may occur in more advanced stages, although it is generally less prominent than in Duchenne muscular dystrophy. Monitoring breathing function becomes important if there are symptoms such as breathlessness, fatigue, sleep-related breathing problems, or recurrent respiratory infections (Muscular Dystrophy Association, 2018; Thada et. al., 2020).
With appropriate multidisciplinary care, including physiotherapy, cardiac surveillance, respiratory support where needed, mobility aids, genetic counselling, and psychosocial support, many individuals with Becker muscular dystrophy can maintain independence, participate in education or work, and have a good quality of life for many years (Cleveland Clinic, 2026; Thada et. al., 2020).
Nutritional perspective
Nutrition plays a supportive role in maintaining muscle strength, energy levels, bone health, cardiac health, and overall wellbeing in Becker muscular dystrophy. While diet cannot alter the underlying genetic cause of the condition, balanced nutrition can help support physical resilience, mobility, and long-term health (Cleveland Clinic, 2022; Thada et. al., 2020).
Adequate protein intake is important for supporting muscle maintenance and repair. Protein-rich foods such as pulses, lentils, beans, eggs, dairy, fish, lean meat, nuts, and seeds may help support muscle tissue and general strength, especially when combined with appropriate physical activity or physiotherapy guidance.
Maintaining a healthy body weight is also important. Excess weight may place additional strain on weakened muscles and joints, making movement, balance, and mobility more difficult. On the other hand, unintentional weight loss or poor intake may worsen fatigue, weakness, and reduced functional capacity (Cleveland Clinic, 2026; Muscular Dystrophy Association, 2018).
Because Becker muscular dystrophy can affect mobility and bone strength, adequate calcium and vitamin D intake may help support bone health. Sources may include dairy products, fortified foods, leafy greens, nuts, seeds, and safe sunlight exposure where appropriate.
Heart health should also be considered, as Becker muscular dystrophy may involve cardiomyopathy in some individuals. A heart-supportive diet rich in fruits, vegetables, whole grains, healthy fats, and minimally processed foods may help support cardiovascular wellbeing alongside regular cardiac monitoring (Hopkins medicine, n.d.; Thada et. al., 2020).
Hydration and regular balanced meals can help support energy levels, digestion, and overall comfort. Nutritional advice should be individualised, especially if there are swallowing difficulties, reduced mobility, weight changes, cardiac concerns, or respiratory involvement.
Psychological perspective
Becker muscular dystrophy can have a significant psychological and emotional impact, particularly because it is a lifelong progressive condition that may affect mobility, independence, physical confidence, and long-term health planning. Individuals may experience frustration, anxiety, low mood, or emotional fatigue as symptoms change over time or begin to interfere with daily activities (Cleveland Clinic, 2022; Thada et. al., 2020).
Muscle weakness, fatigue, cramps, difficulty climbing stairs, reduced exercise tolerance, or the need for mobility support may affect self-esteem, social participation, education, work, and relationships. Young people and adults may find it emotionally challenging when physical ability changes gradually or when they feel different from peers (Muscular Dystrophy Association, 2018).
The possibility of cardiac involvement, even when muscle symptoms are mild, may also create anxiety about future health and the need for ongoing medical monitoring. Regular appointments, tests, and uncertainty about progression can contribute to stress for both individuals and families (Hopkins medicine, n.d.; Cleveland Clinic, 2022).
Family members may also experience emotional strain, particularly when genetic inheritance, carrier status, or future family planning are involved. Genetic counselling and clear communication can help families understand the condition, reduce uncertainty, and make informed decisions (Hopkins medicine, n.d.).
Homeopathic perspective
From a homeopathic perspective, Becker muscular dystrophy may be approached as a chronic constitutional condition involving the individual’s muscular strength, vitality, mobility, energy levels, emotional resilience, and overall wellbeing. As the condition is progressive and inherited, the focus is not only on the muscle weakness itself, but also on how the person experiences and adapts to the condition over time.
Homeopathic assessment is highly individualised. Attention may be given to the pattern of weakness, affected muscle groups, fatigue, cramps, stiffness, walking difficulty, exercise tolerance, sleep, appetite, emotional state, confidence, fears, family history, and general constitution. The individual’s response to exertion, rest, weather, stress, and daily routine may also be considered.
In Becker muscular dystrophy, supportive homeopathic care may focus on the person’s comfort, stamina, adaptability, emotional balance, and quality of life. Since the condition can affect mobility and independence, the psychological and social aspects are also important, including frustration, self-esteem, anxiety about progression, and the need for long-term support.
A holistic approach may include homeopathic support alongside physiotherapy, cardiac monitoring, respiratory assessment, nutritional support, mobility care, genetic counselling, and psychological support. This is especially important because Becker muscular dystrophy can involve the heart muscle, even when skeletal muscle symptoms appear mild.
Summary
Becker muscular dystrophy is a rare inherited muscle-wasting condition that causes progressive weakness of skeletal muscles, especially around the hips, thighs, pelvis, shoulders, and trunk. It is caused by changes in the DMD gene, which affects the production or function of dystrophin, a protein needed to protect and stabilise muscle fibres.
Unlike Duchenne muscular dystrophy, Becker muscular dystrophy usually progresses more slowly because some partially functional dystrophin is produced. Symptoms may begin in childhood, adolescence, or adulthood and can include difficulty running, climbing stairs, rising from the floor, muscle cramps, fatigue, frequent falls, calf enlargement, and reduced exercise tolerance.
The condition is usually inherited in an X-linked recessive pattern, meaning it mainly affects males, while females may be carriers and can sometimes develop milder symptoms or cardiac involvement. In some cases, it may occur due to a new genetic variant, even without a known family history.
Complications can include progressive mobility limitation, contractures, pain, falls, reduced independence, respiratory problems in advanced disease, and most importantly cardiomyopathy or heart rhythm abnormalities. Regular cardiac monitoring is therefore essential, even when muscle symptoms appear mild.
The prognosis varies widely, but Becker muscular dystrophy is generally slower progressing than Duchenne muscular dystrophy. A comprehensive approach including physiotherapy, nutritional support, cardiac and respiratory monitoring, genetic counselling, psychological support, and holistic care can help preserve mobility, independence, emotional resilience, and quality of life.
CMA Reflective Practice
| Reflective Practice – CPD Activity This article is valued at one hour of CMA CPD Reading alone is not CPD; reflection is. Work through the prompts below and record your responses in your CPD portfolio. Please access this by logging into your CMA Membership portal. Scope of practice. Becker muscular dystrophy is a genetic, progressive condition requiring specialist multidisciplinary management. Where, precisely, does my contribution begin and end – and how would I articulate that boundary to a client who hoped I could do more? Cardiac vigilance. The article stresses that cardiomyopathy and arrhythmias can develop even when skeletal muscle symptoms appear mild. What symptoms – breathlessness, palpitations, unexplained fatigue, reduced exercise tolerance – would prompt me to pause treatment and advise urgent medical review? Do I have a written referral protocol for this? Working alongside, not instead of. How do I record and communicate with a client’s neurologist, cardiologist, physiotherapist or dietitian? What would I change so that my notes could be shared with a consultant tomorrow without embarrassment? Genetics and family impact. Inheritance, carrier status and family planning are matters for qualified genetic counselling. If a client or a family member asked me about the risk to a sibling or a future child, what exactly would I say, and to whom would I signpost them? Language and expectation. Nothing in complementary practice alters dystrophin production or the course of the condition. Review the words I actually use with clients living with progressive conditions. Would an independent observer judge my language as supportive, or as implying benefits I cannot evidence? The person, not the diagnosis. Frustration, anticipatory anxiety, changing independence and identity are central to this condition. What do I currently offer that genuinely supports emotional resilience – and where might I be exceeding my psychological training? One change I will make: Having reflected on this article, the single change I will make to my practice is … CPD logging tip: Record the date, the title of this Clinical Spotlight, one hour of CPD, and – most importantly – your answer to the commitment line above. CMA CPD submissions are assessed on the quality of reflection and the evidence of applied change, not on hours accumulated. |
References
- Becker Muscular Dystrophy (BMD): Symptoms & Treatment. (2022). In Cleveland Clinic. https://my.clevelandclinic.org/health/diseases/23541-becker-muscular-dystrophy-bmd and https://my.clevelandclinic.org/health/diseases/14128-muscular-dystrophy
- Becker Muscular Dystrophy. (n.d.). In www.hopkinsmedicine.org. Retrieved August 4, 2026, from https://www.hopkinsmedicine.org/health/conditions-and-diseases/becker-muscular-dystrophy
- Muscular Dystrophy Association. (2018). Becker Muscular Dystrophy (BMD) | Muscular Dystrophy Association. In Muscular Dystrophy Association. https://www.mda.org/disease/becker-muscular-dystrophy
- Thada, P. K., Bhandari, J., & Umapathi, K. K. (2020). Becker Muscular Dystrophy. In PubMed. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK556092/
Further Reading
Do dig into the CMA’s extraordinary library of evidence-based articles on a wide variety of medical conditions, therapies, and remedies in our “Learn About” section.
About the Author
Amrita Singh is a qualified Homoeopath, Psychologist, and Nutritionist with a strong multidisciplinary foundation in mind–body health. She holds an MSc in Psychology (UK) and an MSc in Food, Nutrition & Dietetics (India), alongside formal training in classical homoeopathy from the Central College of Homoeopathy, London. She is currently pursuing postgraduate studies with the Irish School of Homoeopathy.
A full member of the Complementary Medical Association (MCMA), Homoeopathy International (R. Hom. Int.), the British Psychological Society (Graduate Member), and Balen’s insured, Amrita integrates emotional insight, nutritional balance, and gentle homoeopathic care in her clinical approach.
Formerly the Head of Department at RMCH&RC, she now works with clients internationally & runs two physical clinics (Meerut City, Uttar Pradesh & Ambala Cantt., Haryana) in India, offering compassionate, holistic guidance that honours the interconnectedness of emotional wellbeing, physical health, and lifestyle patterns.
Contact & Credentials
Amrita Singh
Homoeopath, Psychologist & Nutritionist
Lic; ISH Advanced Homeopathic Therapeutics (Ireland) | Level 7 Psychology (England) | MSc Food, Nutrition & Dietetics (India)
MCMA | R. Hom. Int. (Balen’s Insured) | GMBPsS
📧 [email protected]
🌐 https://amritasingh.co.uk/
📍 United Kingdom
Instagram – https://www.instagram.com/best_doctor.uk2025/
Facebook – https://www.facebook.com/profile.php?id=61582871564526